Annual Current Assets
$134.20 M
+$33.36 M+33.08%
31 December 2023
Summary:
Avadel Pharmaceuticals annual total current assets is currently $134.20 million, with the most recent change of +$33.36 million (+33.08%) on 31 December 2023. During the last 3 years, it has fallen by -$58.29 million (-30.28%). AVDL annual current assets is now -49.06% below its all-time high of $263.45 million, reached on 31 December 2020.AVDL Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$127.26 M
+$1.48 M+1.18%
30 September 2024
Summary:
Avadel Pharmaceuticals quarterly total current assets is currently $127.26 million, with the most recent change of +$1.48 million (+1.18%) on 30 September 2024. Over the past year, it has dropped by -$6.94 million (-5.17%). AVDL quarterly current assets is now -54.82% below its all-time high of $281.69 million, reached on 30 September 2020.AVDL Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVDL Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -5.2% |
| 3 y3 years | -30.3% | -33.9% |
| 5 y5 years | +62.9% | +54.5% |
AVDL Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -30.3% | +33.1% | -33.9% | +26.2% |
| 5 y | 5 years | -49.1% | +62.9% | -54.8% | +54.5% |
| alltime | all time | -49.1% | +1631.2% | -54.8% | +4990.3% |
Avadel Pharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $127.26 M(+1.2%) |
| June 2024 | - | $125.78 M(-7.5%) |
| Mar 2024 | - | $136.03 M(+1.4%) |
| Dec 2023 | $30.50 M(-4.5%) | $134.20 M(-22.1%) |
| Sept 2023 | - | $172.25 M(+0.6%) |
| June 2023 | - | $171.23 M(+56.4%) |
| Mar 2023 | - | $109.47 M(+8.6%) |
| Dec 2022 | $31.94 M(-41.7%) | $100.84 M(-10.9%) |
| Sept 2022 | - | $113.22 M(-9.9%) |
| June 2022 | - | $125.71 M(-21.8%) |
| Mar 2022 | - | $160.74 M(-16.5%) |
| Dec 2021 | $54.77 M(+13.7%) | $192.49 M(-6.5%) |
| Sept 2021 | - | $205.82 M(-10.8%) |
| June 2021 | - | $230.70 M(-4.8%) |
| Mar 2021 | - | $242.31 M(-8.0%) |
| Dec 2020 | $48.18 M(-30.2%) | $263.45 M(-6.5%) |
| Sept 2020 | - | $281.69 M(+1.7%) |
| June 2020 | - | $277.02 M(+111.5%) |
| Mar 2020 | - | $130.97 M(+59.0%) |
| Dec 2019 | $69.06 M(+5.5%) | $82.38 M(-7.0%) |
| Sept 2019 | - | $88.60 M(-8.8%) |
| June 2019 | - | $97.20 M(-5.1%) |
| Mar 2019 | - | $102.44 M(-18.0%) |
| Dec 2018 | $65.45 M(-49.4%) | $124.85 M(-15.6%) |
| Sept 2018 | - | $147.88 M(-15.5%) |
| June 2018 | - | $174.98 M(-24.6%) |
| Mar 2018 | - | $231.93 M(+87.1%) |
| Dec 2017 | $129.30 M(+101.1%) | $123.97 M(-16.8%) |
| Sept 2017 | - | $148.93 M(-27.1%) |
| June 2017 | - | $204.35 M(-0.1%) |
| Mar 2017 | - | $204.61 M(+12.9%) |
| Dec 2016 | $64.30 M(+32.1%) | $181.19 M(+1.9%) |
| Sept 2016 | - | $177.85 M(+0.1%) |
| June 2016 | - | $177.65 M(-1.6%) |
| Mar 2016 | - | $180.47 M(+8.5%) |
| Dec 2015 | $48.68 M(-21.3%) | $166.40 M(+25.9%) |
| June 2015 | - | $132.17 M(+2.2%) |
| Mar 2015 | - | $129.33 M(+15.1%) |
| Dec 2014 | $61.88 M(-25.1%) | $112.32 M(+13.2%) |
| Sept 2014 | - | $99.25 M(-5.6%) |
| June 2014 | - | $105.12 M(-3.3%) |
| Mar 2014 | - | $108.72 M(+223.4%) |
| Dec 2013 | $82.63 M(-10.4%) | $33.62 M(+2.1%) |
| Sept 2013 | - | $32.93 M(-5.8%) |
| June 2013 | - | $34.95 M(-10.9%) |
| Mar 2013 | - | $39.24 M(+56.4%) |
| Dec 2012 | $92.23 M | $25.09 M(-17.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | - | $30.28 M(-7.1%) |
| Mar 2012 | - | $32.60 M(-11.0%) |
| Dec 2011 | $32.75 M(+12.0%) | $36.65 M(-8.4%) |
| Sept 2011 | - | $40.02 M(-4.7%) |
| June 2011 | - | $41.99 M(+13.8%) |
| Mar 2011 | - | $36.91 M(-18.6%) |
| Dec 2010 | $29.25 M(+6.5%) | $45.36 M(-9.7%) |
| Sept 2010 | - | $50.25 M(+6.4%) |
| June 2010 | - | $47.22 M(-16.8%) |
| Mar 2010 | - | $56.78 M(-15.1%) |
| Dec 2009 | $27.45 M(-16.0%) | $66.84 M(-3.5%) |
| Sept 2009 | - | $69.24 M(+17.4%) |
| June 2009 | - | $59.00 M(-0.3%) |
| Mar 2009 | - | $59.19 M(+0.0%) |
| Dec 2008 | $32.67 M(-27.9%) | $59.19 M(+19.3%) |
| Sept 2008 | - | $49.60 M(-5.1%) |
| June 2008 | - | $52.27 M(-8.3%) |
| Mar 2008 | - | $56.98 M(+1.5%) |
| Dec 2007 | $45.29 M(+18.8%) | $56.11 M(-8.9%) |
| Sept 2007 | - | $61.60 M(-1.7%) |
| June 2007 | - | $62.67 M(-8.0%) |
| Mar 2007 | - | $68.15 M(-11.2%) |
| Dec 2006 | $38.12 M(+17.8%) | $76.78 M(-2.5%) |
| Sept 2006 | - | $78.75 M(-1.6%) |
| June 2006 | - | $80.04 M(-4.4%) |
| Mar 2006 | - | $83.71 M(-9.0%) |
| Dec 2005 | $32.36 M(+30.3%) | $91.99 M(-9.5%) |
| Sept 2005 | - | $101.60 M(-13.0%) |
| June 2005 | - | $116.79 M(-5.4%) |
| Mar 2005 | - | $123.42 M(+2.2%) |
| Dec 2004 | $24.84 M(+281.1%) | $120.77 M(+8.7%) |
| Sept 2004 | - | $111.07 M(0.0%) |
| June 2004 | - | $111.07 M(-5.8%) |
| Mar 2004 | - | $117.85 M(-2.4%) |
| Dec 2003 | $6.52 M(+49.3%) | $120.73 M(+322.3%) |
| Sept 2003 | - | $28.59 M(+45.4%) |
| June 2003 | - | $19.66 M(+2.3%) |
| Mar 2003 | - | $19.22 M(+2.7%) |
| Dec 2002 | $4.37 M(+0.5%) | $18.71 M(+2.5%) |
| Sept 2002 | - | $18.26 M(+32.3%) |
| Dec 2001 | $4.34 M(-31.0%) | $13.80 M(-1.9%) |
| Dec 2000 | $6.30 M(-12.1%) | $14.06 M(+81.4%) |
| Dec 1999 | $7.17 M(-19.3%) | $7.75 M(-52.8%) |
| Dec 1998 | $8.88 M(+28.7%) | $16.44 M(+39.3%) |
| Mar 1998 | - | $11.80 M(-19.2%) |
| Dec 1997 | $6.90 M(-43.0%) | $14.60 M(-18.0%) |
| Dec 1996 | $12.10 M | $17.80 M(+612.0%) |
| Mar 1996 | - | $2.50 M |
FAQ
- What is Avadel Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly current assets year-on-year change?
What is Avadel Pharmaceuticals annual total current assets?
The current annual current assets of AVDL is $134.20 M
What is the all time high annual current assets for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual total current assets is $263.45 M
What is Avadel Pharmaceuticals quarterly total current assets?
The current quarterly current assets of AVDL is $127.26 M
What is the all time high quarterly current assets for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly total current assets is $281.69 M
What is Avadel Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, AVDL quarterly total current assets has changed by -$6.94 M (-5.17%)